Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.

Richard E PratleySamuel Dagogo-JackBernard CharbonnelShrita PatelAnne HickmanJie LiuLisa TarasenkoAnnpey PongMisoo C EllisonSusan HuyckIra GantzSteven G Terra

Published in: Diabetes, obesity & metabolism (2020)

Ertugliflozin improved glycaemic control, BW and SBP in younger and older individuals with T2D and was generally well tolerated in both groups.

Keyphrases

phase iii
open label
clinical trial
community dwelling
middle aged
physical activity
type diabetes
double blind
phase ii
placebo controlled
case control
study protocol